South Korea Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027

Growth Outlook

• The 2027 portion of the South Korea Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 158 Mn in 2026 and is projected to reach USD 172 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
• By 2027, Anti-Infectives alone is expected to reach USD 56 Mn, with Others at USD 43 Mn.

Market Dynamics

South Korea's Companion Animal Healthcare Market is witnessing a steady demand and growth in recent years. One of the main factors driving this demand is the increasing pet ownership and expenditure on pet healthcare. As of 2019, South Korea has the highest pet ownership rate in Asia, with over 30% of households owning a pet. This is expected to further increase in the coming years, leading to a significant rise in demand for companion animal healthcare.

Pharmaceuticals account for a major share in the companion animal healthcare market in South Korea. The market is expected to grow at a CAGR of around 5% between 2018-2027, reaching a value of over USD million by the end of the forecast period. The major factors driving this growth are the rising number of pet product releases, increased focus on research and development, and advancements in the veterinary medical industry.

One of the key trends in the South Korean companion animal healthcare market is the increasing use of innovative pharmaceuticals for the treatment of various diseases in pets. Veterinarians and pet owners are preferring pharmaceuticals that are not only effective but also safe for the animals in the long term. This has led to an increase in the demand for novel and advanced medications that cater to specific pet health concerns, leading to a rise in the overall sales of pharmaceuticals.

Another factor contributing to the demand for companion animal healthcare pharmaceuticals in South Korea is the increasing awareness among pet owners about the importance of preventive care for their furry companions. This has led to a rise in demand for preventive medications such as flea and tick treatments, heartworm preventives, and vaccines. With the pet population expected to continue to rise, the demand for these preventive medications is also expected to grow, driving the overall demand for pharmaceuticals in the market.

Furthermore, the growing inclination towards natural and organic products in the healthcare industry has also impacted the companion animal healthcare market in South Korea. Pet owners are increasingly seeking natural and organic alternatives to traditional medications for their pets, leading to a surge in demand for herbal and homeopathic products. This trend is expected to further boost the pharmaceutical segment of the market in the coming years.

In conclusion, the South Korea Companion Animal Healthcare Market is witnessing a steady demand and growth for pharmaceuticals as a result of the rising pet ownership, increasing awareness about pet healthcare, and the growing demand for natural and preventive medications. With the market projected to continue to grow in the coming years, pharmaceutical companies have a significant opportunity to tap into this lucrative market and cater to the evolving demands of pet owners.